Literature DB >> 21380938

Evolving concepts of the role of high-density lipoprotein in protection from atherosclerosis.

John A Farmer1, Joshua Liao.   

Abstract

High-density lipoprotein (HDL) is classified as a negative risk factor due to the inverse relationship between elevated levels of HDL cholesterol and atherosclerosis. The mechanism by which HDL can mediate protection from atherosclerosis is complex and multifactorial. The primary role of reverse cholesterol transport in the reduction of risk for coronary artery disease is supported by a considerable amount of experimental data. HDL is able to interact with and remove cholesterol from the lipid-laden foam cells in the peripheral vasculature with subsequent transportation to the liver for excretion. However, HDL has multiple other physiologic effects that may play a significant role in protection from atherosclerosis. HDL has been demonstrated to exhibit multiple beneficial effects on the coagulation system. Platelet function is improved by both direct and indirect mechanisms. HDL has a complex interaction with the protein C and protein S system. Thrombolytic balance is also improved by HDL. HDL has been demonstrated to have a significant natural antioxidant effect that inhibits the oxidative step required for low-density lipoprotein uptake by the macrophage. Additionally, HDL has also been demonstrated to exert multiple beneficial effects on endothelial function, including decreased apoptosis and endothelial repair.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21380938     DOI: 10.1007/s11883-011-0166-3

Source DB:  PubMed          Journal:  Curr Atheroscler Rep        ISSN: 1523-3804            Impact factor:   5.113


  44 in total

1.  The "common soil hypothesis": evidence from population studies?

Authors:  Maria Benedetta Donati
Journal:  Thromb Res       Date:  2010-04       Impact factor: 3.944

Review 2.  The year in atherothrombosis.

Authors:  Pedro R Moreno; Valentin Fuster
Journal:  J Am Coll Cardiol       Date:  2004-12-07       Impact factor: 24.094

3.  Evidence that high-density lipoprotein cholesterol is an independent predictor of acute platelet-dependent thrombus formation.

Authors:  T Z Naqvi; P K Shah; P A Ivey; M D Molloy; A M Thomas; S Panicker; A Ahmed; B Cercek; S Kaul
Journal:  Am J Cardiol       Date:  1999-11-01       Impact factor: 2.778

4.  Paraoxonase inhibits high-density lipoprotein oxidation and preserves its functions. A possible peroxidative role for paraoxonase.

Authors:  M Aviram; M Rosenblat; C L Bisgaier; R S Newton; S L Primo-Parmo; B N La Du
Journal:  J Clin Invest       Date:  1998-04-15       Impact factor: 14.808

5.  Stimulation of arterial endothelial cell prostacyclin synthesis by high density lipoproteins.

Authors:  L N Fleisher; A R Tall; L D Witte; R W Miller; P J Cannon
Journal:  J Biol Chem       Date:  1982-06-25       Impact factor: 5.157

6.  Reconstituted high density lipoprotein (rHDL) modulates platelet activity in vitro and ex vivo.

Authors:  P G Lerch; M O Spycher; J E Doran
Journal:  Thromb Haemost       Date:  1998-08       Impact factor: 5.249

Review 7.  The role of dysfunctional HDL in atherosclerosis.

Authors:  Mohamad Navab; Srinivasa T Reddy; Brian J Van Lenten; G M Anantharamaiah; Alan M Fogelman
Journal:  J Lipid Res       Date:  2008-10-27       Impact factor: 5.922

Review 8.  Diabetes and cardiovascular disease. The "common soil" hypothesis.

Authors:  M P Stern
Journal:  Diabetes       Date:  1995-04       Impact factor: 9.461

9.  High-density lipoprotein transport through aortic endothelial cells involves scavenger receptor BI and ATP-binding cassette transporter G1.

Authors:  Lucia Rohrer; Pascale M Ohnsorg; Marc Lehner; Franziska Landolt; Franz Rinninger; Arnold von Eckardstein
Journal:  Circ Res       Date:  2009-04-16       Impact factor: 17.367

10.  Lipids and risk of coronary heart disease. The Framingham Study.

Authors:  W P Castelli; K Anderson; P W Wilson; D Levy
Journal:  Ann Epidemiol       Date:  1992 Jan-Mar       Impact factor: 3.797

View more
  12 in total

Review 1.  Vascular disease and dementias: paradigm shifts to drive research in new directions.

Authors:  Mitchel A Kling; John Q Trojanowski; David A Wolk; Virginia M Y Lee; Steven E Arnold
Journal:  Alzheimers Dement       Date:  2012-11-22       Impact factor: 21.566

2.  Cardioprotective effects of red wine and vodka in a model of endothelial dysfunction.

Authors:  Antonio D Lassaletta; Louis M Chu; Nassrene Y Elmadhun; Thomas A Burgess; Jun Feng; Michael P Robich; Frank W Sellke
Journal:  J Surg Res       Date:  2012-06-21       Impact factor: 2.192

Review 3.  Synthetic high-density lipoprotein-like nanoparticles as cancer therapy.

Authors:  Kaylin M McMahon; Linda Foit; Nicholas L Angeloni; Francis J Giles; Leo I Gordon; C Shad Thaxton
Journal:  Cancer Treat Res       Date:  2015

Review 4.  High-density lipoproteins for the systemic delivery of short interfering RNA.

Authors:  Kaylin Marie McMahon; Colby Shad Thaxton
Journal:  Expert Opin Drug Deliv       Date:  2013-12-09       Impact factor: 6.648

5.  Effect of hepatic and renal impairment on the pharmacokinetics of dalcetrapib: altered distribution of the active thiol?

Authors:  Mary Phelan; Judith Anzures-Cabrera; David J Carlile; Lucy Rowell; Olaf Kuhlmann; Gerhard Arold; Richard Robson; Darren Bentley
Journal:  Clin Pharmacokinet       Date:  2013-04       Impact factor: 6.447

6.  Association between Perchlorate and Indirect Indicators of Thyroid Dysfunction in NHANES 2001-2002, a Cross-Sectional, Hypothesis-Generating Study.

Authors:  Dina M Schreinemachers
Journal:  Biomark Insights       Date:  2011-12-01

7.  Pla2g12b and Hpn are genes identified by mouse ENU mutagenesis that affect HDL cholesterol.

Authors:  Aleksandra Aljakna; Seungbum Choi; Holly Savage; Rachael Hageman Blair; Tongjun Gu; Karen L Svenson; Gary A Churchill; Matt Hibbs; Ron Korstanje
Journal:  PLoS One       Date:  2012-08-17       Impact factor: 3.240

8.  Low HDL-C level is associated with the development of intracranial artery stenosis: analysis from the Chinese IntraCranial AtheroSclerosis (CICAS) study.

Authors:  Yining Qian; Yuehua Pu; Liping Liu; David Z Wang; Xingquan Zhao; Chunxue Wang; Yilong Wang; Gaifen Liu; Yuesong Pan; Yongjun Wang
Journal:  PLoS One       Date:  2013-05-17       Impact factor: 3.240

9.  An agomir of miR-144-3p accelerates plaque formation through impairing reverse cholesterol transport and promoting pro-inflammatory cytokine production.

Authors:  Yan-Wei Hu; Ya-Rong Hu; Jia-Yi Zhao; Shu-Fen Li; Xin Ma; Shao-Guo Wu; Jing-Bo Lu; Yu-Rong Qiu; Yan-Hua Sha; Yan-Chao Wang; Ji-Juan Gao; Lei Zheng; Qian Wang
Journal:  PLoS One       Date:  2014-04-14       Impact factor: 3.240

10.  A Cross-Sectional Study Demonstrating Increased Serum Amyloid A Related Inflammation in High-Density Lipoproteins from Subjects with Type 1 Diabetes Mellitus and How this Association Was Augmented by Poor Glycaemic Control.

Authors:  Jane McEneny; Jane-Ann Daniels; Anne McGowan; Anjuli Gunness; Kevin Moore; Michael Stevenson; Ian S Young; James Gibney
Journal:  J Diabetes Res       Date:  2015-10-18       Impact factor: 4.011

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.